Company Progenics Pharmaceuticals, Inc.

Stocks

US7431871067

Biotechnology & Medical Research

Business description: Progenics Pharmaceuticals, Inc.

Sales by Activity: Progenics Pharmaceuticals, Inc.

Executive Committee: Progenics Pharmaceuticals, Inc.

Company details: Progenics Pharmaceuticals, Inc.

Bio Therapeutic Drugs

Sector

Inactive Instrument

Progenics Pharmaceuticals, Inc. is engaged in developing medicines and other products for targeting and treating cancer. The Company's pipeline includes therapeutic agents designed to target cancer (AZEDRA and 1095); prostate specific membrane antigen (PSMA)-targeted imaging agents for prostate cancer (1404 and PyL), and imaging analysis tools. It also includes commercial product, RELISTOR (methylnaltrexone bromide) for opioid-induced constipation. AZEDRA is a radiotherapeutic product candidate in development as a treatment for malignant and/or recurrent pheochromocytoma and paraganglioma, rare tumors found in the adrenal glands and outside of the adrenal glands, respectively. RELISTOR is a treatment for opioid induced constipation. PyL is a clinical-stage, fluorinated PSMA-targeted Positron Emission Topography (PET) imaging agent for prostate cancer. PSMA TTC is a thorium-227 labeled PSMA-targeted antibody therapeutic.

Fiscal Period: December	2019 (USD)
Pharmaceuticals	34.99M

See all business segments

Manager	Title	Age	Since
David Mims CEO	Chief Executive Officer	62	-

See PROGENICS PHARMACEUTICALS, INC. governance

Progenics Pharmaceuticals, Inc.

One World Trade Center

10007-0089, New York

http://progenics.com

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.84%	-0.66%	+59.82%	+92.96%	54.88B
ARGENX SE	-4.14%	-8.06%	+58.96%	+118.67%	54.63B
INSMED INCORPORATED	-2.24%	+3.59%	+17.75%	+477.47%	25.06B
BIONTECH SE	-1.60%	-6.21%	-18.96%	-15.21%	23.14B
WUXI BIOLOGICS (CAYMAN) INC.	+2.43%	+1.06%	+42.44%	-1.27%	19.88B
GENMAB A/S	-3.19%	0.00%	+35.60%	-26.98%	17.55B
PHARMAESSENTIA CORPORATION	-6.84%	+2.18%	+195.12%	+357.18%	16.5B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+8.74%	+3.51%	+51.91%	+726.40%	15.36B
EXELIXIS, INC.	-1.05%	+1.16%	+25.95%	+194.27%	14.2B
Average	-0.67%	-0.28%	+52.07%	+213.72%	26.8B
Weighted average by Cap.	-0.91%	-1.46%	+51.26%	+176.25%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs